aluates Reports

$ 0.0

Automative

Global Metastatic Melanoma Diagnostic Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-20C4912

Global Metastatic Melanoma Diagnostic Market Insights Forecast to 2028

BUY CHAPTERS

Global Metastatic Melanoma Diagnostic Market Research Report 2025

Code: QYRE-Auto-20C4912

Report

June 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Myriad Genetics

Abbott Laboratories

Foundation Medicine

Pathway Genomics Corporation

Cancer Genetics

Castle Biosciences

NeoGenomics

DermTech

Sysmex Inostics

Metastatic Melanoma Diagnostic Market Size

The global market for Metastatic Melanoma Diagnostic was valued at US$ 822 million in the year 2024 and is projected to reach a revised size of US$ 1389 million by 2031, growing at a CAGR of 7.9% during the forecast period.

Metastatic Melanoma Diagnostic Market

Melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. When it spreads to other places in body, it"s called metastatic, or advanced. Although in many cases metastatic melanoma can’t be cured, treatments and support can help people live longer and better. Doctors have therapies that have greatly increased survival rates. And researchers are working to find new medications that can do even more.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Metastatic Melanoma Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Melanoma Diagnostic.

The Metastatic Melanoma Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metastatic Melanoma Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Metastatic Melanoma Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Metastatic Melanoma Diagnostic Market Report

Report Metric	Details
Report Name	Metastatic Melanoma Diagnostic Market
Accounted market size in year	US$ 822 million
Forecasted market size in 2031	US$ 1389 million
CAGR	7.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	BRAF Mutation Circulating Tumor Cells (CTCs) Immunohistochemistry Others
Segment by Application	Pathology Laboratories Hospitals Cancer Research Centres Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Melanoma Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Metastatic Melanoma Diagnostic Market growing?

Ans: The Metastatic Melanoma Diagnostic Market witnessing a CAGR of 7.9% during the forecast period 2025-2031.

What is the Metastatic Melanoma Diagnostic Market size in 2031?

Ans: The Metastatic Melanoma Diagnostic Market size in 2031 will be US$ 1389 million.

Who are the main players in the Metastatic Melanoma Diagnostic Market report?

Ans: The main players in the Metastatic Melanoma Diagnostic Market are Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech, Sysmex Inostics

What are the Application segmentation covered in the Metastatic Melanoma Diagnostic Market report?

Ans: The Applications covered in the Metastatic Melanoma Diagnostic Market report are Pathology Laboratories, Hospitals, Cancer Research Centres, Others

What are the Type segmentation covered in the Metastatic Melanoma Diagnostic Market report?

Ans: The Types covered in the Metastatic Melanoma Diagnostic Market report are BRAF Mutation, Circulating Tumor Cells (CTCs), Immunohistochemistry, Others

Recommended Reports

Cancer Diagnostics

Skin Cancers

Cancer Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 BRAF Mutation

1.2.3 Circulating Tumor Cells (CTCs)

1.2.4 Immunohistochemistry

1.2.5 Others

1.3 Market by Application

1.3.1 Global Metastatic Melanoma Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pathology Laboratories

1.3.3 Hospitals

1.3.4 Cancer Research Centres

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Metastatic Melanoma Diagnostic Market Perspective (2020-2031)

2.2 Global Metastatic Melanoma Diagnostic Growth Trends by Region

2.2.1 Global Metastatic Melanoma Diagnostic Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Metastatic Melanoma Diagnostic Historic Market Size by Region (2020-2025)

2.2.3 Metastatic Melanoma Diagnostic Forecasted Market Size by Region (2026-2031)

2.3 Metastatic Melanoma Diagnostic Market Dynamics

2.3.1 Metastatic Melanoma Diagnostic Industry Trends

2.3.2 Metastatic Melanoma Diagnostic Market Drivers

2.3.3 Metastatic Melanoma Diagnostic Market Challenges

2.3.4 Metastatic Melanoma Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Metastatic Melanoma Diagnostic Players by Revenue

3.1.1 Global Top Metastatic Melanoma Diagnostic Players by Revenue (2020-2025)

3.1.2 Global Metastatic Melanoma Diagnostic Revenue Market Share by Players (2020-2025)

3.2 Global Metastatic Melanoma Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Metastatic Melanoma Diagnostic Revenue

3.4 Global Metastatic Melanoma Diagnostic Market Concentration Ratio

3.4.1 Global Metastatic Melanoma Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Metastatic Melanoma Diagnostic Revenue in 2024

3.5 Global Key Players of Metastatic Melanoma Diagnostic Head office and Area Served

3.6 Global Key Players of Metastatic Melanoma Diagnostic, Product and Application

3.7 Global Key Players of Metastatic Melanoma Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Melanoma Diagnostic Breakdown Data by Type

4.1 Global Metastatic Melanoma Diagnostic Historic Market Size by Type (2020-2025)

4.2 Global Metastatic Melanoma Diagnostic Forecasted Market Size by Type (2026-2031)

5 Metastatic Melanoma Diagnostic Breakdown Data by Application

5.1 Global Metastatic Melanoma Diagnostic Historic Market Size by Application (2020-2025)

5.2 Global Metastatic Melanoma Diagnostic Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Metastatic Melanoma Diagnostic Market Size (2020-2031)

6.2 North America Metastatic Melanoma Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Metastatic Melanoma Diagnostic Market Size by Country (2020-2025)

6.4 North America Metastatic Melanoma Diagnostic Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Metastatic Melanoma Diagnostic Market Size (2020-2031)

7.2 Europe Metastatic Melanoma Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Metastatic Melanoma Diagnostic Market Size by Country (2020-2025)

7.4 Europe Metastatic Melanoma Diagnostic Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Metastatic Melanoma Diagnostic Market Size (2020-2031)

8.2 Asia-Pacific Metastatic Melanoma Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Metastatic Melanoma Diagnostic Market Size by Region (2020-2025)

8.4 Asia-Pacific Metastatic Melanoma Diagnostic Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Metastatic Melanoma Diagnostic Market Size (2020-2031)

9.2 Latin America Metastatic Melanoma Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Metastatic Melanoma Diagnostic Market Size by Country (2020-2025)

9.4 Latin America Metastatic Melanoma Diagnostic Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Metastatic Melanoma Diagnostic Market Size (2020-2031)

10.2 Middle East & Africa Metastatic Melanoma Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Country (2020-2025)

10.4 Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Myriad Genetics

11.1.1 Myriad Genetics Company Details

11.1.2 Myriad Genetics Business Overview

11.1.3 Myriad Genetics Metastatic Melanoma Diagnostic Introduction

11.1.4 Myriad Genetics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.1.5 Myriad Genetics Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Metastatic Melanoma Diagnostic Introduction

11.2.4 Abbott Laboratories Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.2.5 Abbott Laboratories Recent Development

11.3 Foundation Medicine

11.3.1 Foundation Medicine Company Details

11.3.2 Foundation Medicine Business Overview

11.3.3 Foundation Medicine Metastatic Melanoma Diagnostic Introduction

11.3.4 Foundation Medicine Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.3.5 Foundation Medicine Recent Development

11.4 Pathway Genomics Corporation

11.4.1 Pathway Genomics Corporation Company Details

11.4.2 Pathway Genomics Corporation Business Overview

11.4.3 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Introduction

11.4.4 Pathway Genomics Corporation Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.4.5 Pathway Genomics Corporation Recent Development

11.5 Cancer Genetics

11.5.1 Cancer Genetics Company Details

11.5.2 Cancer Genetics Business Overview

11.5.3 Cancer Genetics Metastatic Melanoma Diagnostic Introduction

11.5.4 Cancer Genetics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.5.5 Cancer Genetics Recent Development

11.6 Castle Biosciences

11.6.1 Castle Biosciences Company Details

11.6.2 Castle Biosciences Business Overview

11.6.3 Castle Biosciences Metastatic Melanoma Diagnostic Introduction

11.6.4 Castle Biosciences Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.6.5 Castle Biosciences Recent Development

11.7 NeoGenomics

11.7.1 NeoGenomics Company Details

11.7.2 NeoGenomics Business Overview

11.7.3 NeoGenomics Metastatic Melanoma Diagnostic Introduction

11.7.4 NeoGenomics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.7.5 NeoGenomics Recent Development

11.8 Dermtech

11.8.1 Dermtech Company Details

11.8.2 Dermtech Business Overview

11.8.3 Dermtech Metastatic Melanoma Diagnostic Introduction

11.8.4 Dermtech Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.8.5 Dermtech Recent Development

11.9 Sysmex Inostics

11.9.1 Sysmex Inostics Company Details

11.9.2 Sysmex Inostics Business Overview

11.9.3 Sysmex Inostics Metastatic Melanoma Diagnostic Introduction

11.9.4 Sysmex Inostics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025)

11.9.5 Sysmex Inostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Myriad Genetics

Abbott Laboratories

Foundation Medicine

Pathway Genomics Corporation

Cancer Genetics

Castle Biosciences

NeoGenomics

DermTech

Sysmex Inostics

List of Tables

Table 1. Global Metastatic Melanoma Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of BRAF Mutation

Table 3. Key Players of Circulating Tumor Cells (CTCs)

Table 4. Key Players of Immunohistochemistry

Table 5. Key Players of Others

Table 6. Global Metastatic Melanoma Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Metastatic Melanoma Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Metastatic Melanoma Diagnostic Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Metastatic Melanoma Diagnostic Market Share by Region (2020-2025)

Table 10. Global Metastatic Melanoma Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Metastatic Melanoma Diagnostic Market Share by Region (2026-2031)

Table 12. Metastatic Melanoma Diagnostic Market Trends

Table 13. Metastatic Melanoma Diagnostic Market Drivers

Table 14. Metastatic Melanoma Diagnostic Market Challenges

Table 15. Metastatic Melanoma Diagnostic Market Restraints

Table 16. Global Metastatic Melanoma Diagnostic Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Metastatic Melanoma Diagnostic Market Share by Players (2020-2025)

Table 18. Global Top Metastatic Melanoma Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Melanoma Diagnostic as of 2024)

Table 19. Ranking of Global Top Metastatic Melanoma Diagnostic Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Metastatic Melanoma Diagnostic Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Metastatic Melanoma Diagnostic, Headquarters and Area Served

Table 22. Global Key Players of Metastatic Melanoma Diagnostic, Product and Application

Table 23. Global Key Players of Metastatic Melanoma Diagnostic, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Metastatic Melanoma Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Metastatic Melanoma Diagnostic Revenue Market Share by Type (2020-2025)

Table 27. Global Metastatic Melanoma Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Metastatic Melanoma Diagnostic Revenue Market Share by Type (2026-2031)

Table 29. Global Metastatic Melanoma Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Metastatic Melanoma Diagnostic Revenue Market Share by Application (2020-2025)

Table 31. Global Metastatic Melanoma Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Metastatic Melanoma Diagnostic Revenue Market Share by Application (2026-2031)

Table 33. North America Metastatic Melanoma Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Metastatic Melanoma Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Metastatic Melanoma Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Metastatic Melanoma Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Metastatic Melanoma Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Metastatic Melanoma Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Metastatic Melanoma Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Metastatic Melanoma Diagnostic Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Metastatic Melanoma Diagnostic Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Metastatic Melanoma Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Metastatic Melanoma Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Metastatic Melanoma Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Metastatic Melanoma Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Metastatic Melanoma Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 48. Myriad Genetics Company Details

Table 49. Myriad Genetics Business Overview

Table 50. Myriad Genetics Metastatic Melanoma Diagnostic Product

Table 51. Myriad Genetics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 52. Myriad Genetics Recent Development

Table 53. Abbott Laboratories Company Details

Table 54. Abbott Laboratories Business Overview

Table 55. Abbott Laboratories Metastatic Melanoma Diagnostic Product

Table 56. Abbott Laboratories Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 57. Abbott Laboratories Recent Development

Table 58. Foundation Medicine Company Details

Table 59. Foundation Medicine Business Overview

Table 60. Foundation Medicine Metastatic Melanoma Diagnostic Product

Table 61. Foundation Medicine Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 62. Foundation Medicine Recent Development

Table 63. Pathway Genomics Corporation Company Details

Table 64. Pathway Genomics Corporation Business Overview

Table 65. Pathway Genomics Corporation Metastatic Melanoma Diagnostic Product

Table 66. Pathway Genomics Corporation Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 67. Pathway Genomics Corporation Recent Development

Table 68. Cancer Genetics Company Details

Table 69. Cancer Genetics Business Overview

Table 70. Cancer Genetics Metastatic Melanoma Diagnostic Product

Table 71. Cancer Genetics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 72. Cancer Genetics Recent Development

Table 73. Castle Biosciences Company Details

Table 74. Castle Biosciences Business Overview

Table 75. Castle Biosciences Metastatic Melanoma Diagnostic Product

Table 76. Castle Biosciences Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 77. Castle Biosciences Recent Development

Table 78. NeoGenomics Company Details

Table 79. NeoGenomics Business Overview

Table 80. NeoGenomics Metastatic Melanoma Diagnostic Product

Table 81. NeoGenomics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 82. NeoGenomics Recent Development

Table 83. Dermtech Company Details

Table 84. Dermtech Business Overview

Table 85. Dermtech Metastatic Melanoma Diagnostic Product

Table 86. Dermtech Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 87. Dermtech Recent Development

Table 88. Sysmex Inostics Company Details

Table 89. Sysmex Inostics Business Overview

Table 90. Sysmex Inostics Metastatic Melanoma Diagnostic Product

Table 91. Sysmex Inostics Revenue in Metastatic Melanoma Diagnostic Business (2020-2025) & (US$ Million)

Table 92. Sysmex Inostics Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Metastatic Melanoma Diagnostic Picture

Figure 2. Global Metastatic Melanoma Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Metastatic Melanoma Diagnostic Market Share by Type: 2024 VS 2031

Figure 4. BRAF Mutation Features

Figure 5. Circulating Tumor Cells (CTCs) Features

Figure 6. Immunohistochemistry Features

Figure 7. Others Features

Figure 8. Global Metastatic Melanoma Diagnostic Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Metastatic Melanoma Diagnostic Market Share by Application: 2024 VS 2031

Figure 10. Pathology Laboratories Case Studies

Figure 11. Hospitals Case Studies

Figure 12. Cancer Research Centres Case Studies

Figure 13. Others Case Studies

Figure 14. Metastatic Melanoma Diagnostic Report Years Considered

Figure 15. Global Metastatic Melanoma Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Metastatic Melanoma Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Metastatic Melanoma Diagnostic Market Share by Region: 2024 VS 2031

Figure 18. Global Metastatic Melanoma Diagnostic Market Share by Players in 2024

Figure 19. Global Top Metastatic Melanoma Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Melanoma Diagnostic as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Metastatic Melanoma Diagnostic Revenue in 2024

Figure 21. North America Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Metastatic Melanoma Diagnostic Market Share by Country (2020-2031)

Figure 23. United States Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Metastatic Melanoma Diagnostic Market Share by Country (2020-2031)

Figure 27. Germany Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Metastatic Melanoma Diagnostic Market Share by Region (2020-2031)

Figure 35. China Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Metastatic Melanoma Diagnostic Market Share by Country (2020-2031)

Figure 43. Mexico Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Metastatic Melanoma Diagnostic Market Share by Country (2020-2031)

Figure 47. Turkey Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Metastatic Melanoma Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Myriad Genetics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 51. Abbott Laboratories Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 52. Foundation Medicine Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 53. Pathway Genomics Corporation Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 54. Cancer Genetics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 55. Castle Biosciences Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 56. NeoGenomics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 57. Dermtech Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 58. Sysmex Inostics Revenue Growth Rate in Metastatic Melanoma Diagnostic Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Melanoma Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Metastatic Cancer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intraocular Melanoma Treatment Market Research Report 2025

Global Metastatic Colorectal Cancer Surgery Market Research Report 2024

Global Metastatic Bones Cancer Market Insights Forecast to 2030

Global Metastatic Bones Cancer Medication Treatment Market Insights Forecast to 2030

Global Uveal Melanoma Treatment Market Research Report 2024

Global Melanoma Diagnostics and Therapeutics Market Research Report 2024

Global Skin Cancer Therapeutics Market Research Report 2024

Global Metastatic Bone Tumor Treatment Market Insights Forecast to 2030

Melanoma Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Melanoma Drugs Market Insights Forecast to 2030

Melanoma Skin Cancer Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lentigo Maligna Melanoma Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metastatic Malignant Melanoma Therapy Market Insights Forecast to 2030

Global Colorectal Cancer Therapeutics Market Research Report 2024

Skin Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circulating Tumor Cell Detection System Market Research Report 2024

Global Non Melanoma Skin Cancer Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions